Advisory Services Network’s Anika Therapeutics ANIK Stock Holding History

Advisory Services Network’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12	Closed	-$113	–	1905
2025 Q3	$113	Buy	+12	New	+$115	﹤0.01%	4327
2021 Q3	–	Sell	-377	Closed	-$16K	–	1469
2021 Q2	$16K	Buy	+377	New	+$16.1K	﹤0.01%	2586
2021 Q1	–	Sell	-493	Closed	-$22K	–	1359
2020 Q4	$22K	Hold	493	–	–	﹤0.01%	2098
2020 Q3	$17K	Buy	+493	New	+$17.8K	﹤0.01%	2156
2020 Q2	–	Sell	-493	Closed	-$14K	–	1126
2020 Q1	$14K	Hold	493	–	–	﹤0.01%	2050
2019 Q4	$25K	Sell	493 -86	-15%	-$5K	﹤0.01%	1887
2019 Q3	$24K	Hold	579	–	–	﹤0.01%	1715
2019 Q2	$24K	Buy	579 +162	+39%	+$5.91K	﹤0.01%	1713
2019 Q1	$13K	Buy	417 +329	+374%	+$11.3K	﹤0.01%	1757
2018 Q4	$3K	Hold	88	–	–	﹤0.01%	2179
2018 Q3	$4K	Hold	88	–	–	﹤0.01%	2121
2018 Q2	$4K	Hold	88	–	–	﹤0.01%	2075
2018 Q1	$4K	Hold	88	–	–	﹤0.01%	2175
2017 Q4	$5K	Sell	88 -500	-85%	-$27.7K	﹤0.01%	2089
2017 Q3	$34K	Buy	588 +513	+684%	+$26.8K	﹤0.01%	1231
2017 Q2	$4K	Sell	75 -8	-10%	-$368	﹤0.01%	1866
2017 Q1	$4K	Buy	+83	New	+$3.96K	﹤0.01%	1767

Other funds holding ANIK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Advisory Services Network's ANIK Position: Q4 2025 in Review

Advisory Services Network sold out of Anika Therapeutics (ANIK) in Q4 2025, closing a stake of 12 shares — an estimated $113 sold.

Advisory Services Network first reported a position in ANIK in Q1 2017 and held it in 17 quarters. The position peaked at $34K in Q3 2017. 126 funds tracked by Wall St. Rank hold ANIK as of Q4 2025.

Advisory Services Network reported no remaining Anika Therapeutics position as of Q4 2025 after selling out during the quarter.
Advisory Services Network sold 12 Anika Therapeutics shares in Q4 2025, an estimated $113.
Advisory Services Network first reported a position in Anika Therapeutics in Q1 2017 and held it in 17 quarters.
Advisory Services Network's Anika Therapeutics position peaked at $34K in Q3 2017.
126 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2025.

Based on Advisory Services Network's 13F filing for Q4 2025, filed 17 Feb 2026.